Skip to main content
CRISPR-based antiviral treatment of coronavirus infections

CRISPR-based antiviral treatment of coronavirus infections

Unmet Need The global market for antiviral drugs is a large one, topping $60B, and is getting larger due to the ongoing COVID-19 pandemic. Spurred on by a $3B investment from the U.S. government into…

Read More

A therapeutic vaccine platform for treating influenza viruses

A therapeutic vaccine platform for treating influenza viruses

Value Proposition Influenza virus infections represent a substantial global burden on human health. Each year, it is estimated that influenza viruses cause up to 5 million severe infections globally, resulting in up to 645,000 mortalities.…

Read More

Replication competent bi- and tri-valent influenza viruses as vaccines

Replication competent bi- and tri-valent influenza viruses as vaccines

Value Proposition Influenza infection is a major public health concern, with an estimated 200,000 Americans hospitalized each year with flu or flu-related illness. The most effective method for flu prevention is vaccination, however, due to…

Read More

Compositions and methods for treating gram-negative bacterial infection

Compositions and methods for treating gram-negative bacterial infection

Value Proposition Antimicrobial resistance is considered to be one of the biggest crises facing modern medicine today. Without desperately needed intervention, it is estimated that by 2050 over 10 million deaths per year will be…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us